Lincoln Pharmaceuticals Ltd., India
- Company typePublic
- Founded1979
- HeadquartersAhmedabad, India
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
Lincoln Pharmaceuticals Ltd., India firmographics
Firmographics- Name
- Lincoln Pharmaceuticals Ltd., India
- Legal name
- Lincoln Pharmaceuticals Ltd.
- Website
- https://lincolnpharma.com
- Company type
- Public
- Founded year
- 1979
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Ownership category
- akta.pro rank
Lincoln Pharmaceuticals Ltd., India industry classification
Industry- Product category
- Pharmaceutical Formulations
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- OTC Pain Relief & Fever (Analgesics, Anti-inflammatory, Topical Pain Relief) (CRADAMAC)
- akta.pro secondary industries
- Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity) (HLAIAAAE), Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD), Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK), Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health) (HLAIAAAJ), Compounding Ingredient & API Distributors (Pharma Supply) (HLAIAJAO)
Keywords
Where Lincoln Pharmaceuticals Ltd., India is headquartered
LocationHeadquarters
- HQ city
- Ahmedabad
- HQ country
- India
- HQ region
- Asia
Offices4 records
Markets served
Lincoln Pharmaceuticals Ltd., India business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Supply Chain, Infrastructure
Revenue model
- Pharmaceutical Formulations Sales: Manufacturing and sale of pharmaceutical formulations including tablets, capsules, injectables, syrups, and ointments. Revenue generated through domestic distribution network and international exports to 60+ countries.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels3 records
Lincoln Pharmaceuticals Ltd., India product offering
Product offeringCore offering
Lincoln Pharmaceuticals Ltd. manufactures and markets pharmaceutical formulations including tablets, capsules, injectables, syrups, and ointments across 15 therapeutic areas such as anti-infective, respiratory, gynecology, cardio & CNS, anti-diabetic, and anti-malaria. The company has developed 600+ formulations and 1,700+ registered products, with proprietary novel drug delivery systems (NDDS), Transdermal Absorption Enhancer (TAE) technology, and PROGLET bilayer tablet technology. Products are sold domestically across 26 Indian states and exported to 60+ countries.
Product overview
Lincoln Pharmaceuticals is a pharmaceutical company offering a diverse portfolio of 600+ formulations across 15 therapeutic areas with over 1,700 registered products and 700 in pipeline. The company operates as a unified product portfolio with multiple dosage forms (Tablets, Capsules, Injectables, Syrups, Ointments) and branded products. Key differentiated offerings include innovative drug delivery systems like PA-12 with PROGLET bilayer technology for pain management, Diclofenac Gel portfolio with TAE technology for topical pain relief, and Domi Up (Ondansetron Oral Spray) as a novel NDDS formulation. The company maintains strong presence in anti-infective, respiratory, gynecology, cardio & CNS, anti-diabetic, and anti-malaria therapeutic segments. Products are distributed domestically across 26 states in India through 50,000+ retailers and exported to 60+ countries globally.
Differentiator
Problem solved
Functional benefit
Brands
- Luther Aqua: Pharmaceutical formulation brand
- Nam Cold DX
- Vivian Gel
- PA-12 (PARALIB)
- Prolin
- Nam Cold Z
- Ryno
- Charge-Up
- Domi-Up (Ondansetron Oral Spray)
- Emmufast
- RELAXO/VIVIAN/DIKON/DIFLAME/DORGEL/DICLOGEL/DIKON PLUS/DICLIQUE/ALVIOL/DIPHADIC
Products and services
- Diclofenac Gel Portfolio Topical NSAID gel portfolio featuring proprietary Transdermal Absorption Enhancer (TAE) technology for localized pain relief with minimized systemic exposure. Sold to distributors, pharmacies, and healthcare providers for patient use.
- PA-12 (PARALIB) Bilayer Tablet Bilayer paracetamol 1000mg tablet combining immediate-release and sustained-release layers for pain and fever management across chronic conditions (osteoarthritis, lower back pain) and acute conditions (fever, dental pain, injuries).
- Domi Up (Ondansetron Oral Spray) NDDS (Novel Drug Delivery System) oral spray formulation of Ondansetron for nausea and vomiting management, delivering faster onset of action compared to conventional tablet formulations.
- Vaginal Spray Patented intravaginal delivery spray product for women's health applications.
- Vitamin C + Zinc Tablets Vitamin C and Zinc supplement tablets for immunity and nutritional support.
- Anti-infective Formulations Antibiotic and antimicrobial pharmaceutical formulations for treating infectious diseases across domestic and international markets.
- Anti-malaria Formulations Patented antimalarial drug formulations developed and commercialized for malaria treatment across endemic markets.
- Respiratory System Products Pharmaceutical formulations for respiratory conditions including cough, cold, asthma, and bronchial disorders sold under brands like Nam Cold DX and Nam Cold Z.
- Cardio & CNS Products Cardiovascular and central nervous system pharmaceutical formulations including high-value chronic disease treatments.
- Anti-diabetic Products Pharmaceutical formulations for diabetes management across the chronic disease segment.
Quantifiable outcome
- Consistent profit growth for 10+ consecutive years - one of only 16 Indian companies to achieve this
- +1 more outcomes
Companies that use Lincoln Pharmaceuticals Ltd., India
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles3 records
Lincoln Pharmaceuticals Ltd., India technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Lincoln Pharmaceuticals Ltd., India partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered minor.
- Green Leaf TrustminorEnvironmental NGO focused on sustainable development and environmental conservation in Gujarat through afforestation, watershed management, and water-scarce community support.
- Setu TrustminorGrassroots NGO dedicated to sustainable development and environmental conservation, collaborating on tree plantation drives, lake desilting projects, and water conservation initiatives.
- Vicharta Samuday Samarthan Manch (VSSM)minorNGO focused on supporting drought-prone and rural communities with innovative conservation practices to restore natural resources and promote climate resilience.
- Saptak School of MusicminorPremier music institution in Ahmedabad dedicated to preserving and promoting Indian classical music through education and annual festival. Lincoln Pharma sponsors music education programs and the annual festival.
- Smile FoundationminorNational NGO providing education, healthcare, and livelihood support to underprivileged children and families. Lincoln Pharma backs child education programs and skill-building workshops.
- AASMAAN FoundationminorNGO focusing on child welfare, education, and youth engagement through grassroots initiatives. Supports educational access and youth skill development programs.
- Bharat Ke VeerminorGovernment-backed initiative allowing citizens to contribute to families of martyred soldiers. Lincoln Pharma provides financial assistance to martyr families.
Scale indicators13 records
Recent moves7 records
Expansion highlights5 records
Lincoln Pharmaceuticals Ltd., India competitors and assessment
Company assessmentDirect peers
- Ajanta Pharma: Mid-cap Indian formulations manufacturer with similar India + emerging-markets export mix, multi-therapeutic portfolio, and branded generics strategy. Closely comparable on size, regulatory footprint, and product breadth.
- Natco Pharma: Indian formulations and API manufacturer with parallel focus on oncology, anti-viral, and chronic segments; comparable on the mix of domestic brand-led generics and international expansion posture.
- Alembic Pharmaceuticals: Indian formulations manufacturer with comparable API + finished-dose business, US FDA and EU-GMP approved plants, and overlap in dermatology, anti-infective, and cardiac segments.
- J B Chemicals & Pharmaceuticals: Indian mid-cap pharma with strong domestic field force, OTC and prescription portfolio, and exports across emerging markets—highly comparable on distribution model and therapeutic mix to Lincoln.
- Unichem Laboratories: Indian formulations manufacturer with API operations and exports to regulated and emerging markets, overlapping in cardiovascular, anti-infective, and pain management categories.
- Strides Pharma: Indian pharma manufacturer with significant emerging-markets exports and regulated-market focus, including Africa. Comparable on geographic targeting and oral solid dosage portfolio.
- IPCA Laboratories: Integrated Indian pharma combining API manufacturing with finished formulations across anti-malarial, anti-infective, and chronic care—directly comparable to Lincoln's API + formulations model and target markets.
- Emcure Pharmaceuticals: Indian pharma manufacturer with India domestic + global export model, including women's health, derma, and cardiovascular—therapeutic categories directly overlapping Lincoln's portfolio.
Broad incumbents
- Glenmark Pharmaceuticals: Larger Indian pharma with broader international footprint and R&D scale than Lincoln, but overlapping therapeutic segments (dermatology, respiratory, cardiac) and similar branded-generic positioning.
- Torrent Pharmaceuticals: Larger Indian pharma with strong domestic field force model mirroring Lincoln's 600+ field force approach, plus emerging-markets exports, with overlap in chronic care and cardiovascular segments.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Lincoln Pharmaceuticals Ltd., India social profiles
Digital presenceLincoln Pharmaceuticals Ltd., India compliance and trust
Trust signalCompliance5 records
Lincoln Pharmaceuticals Ltd., India financial estimates
Financial estimateRevenue estimate
Valuation estimate
Lincoln Pharmaceuticals Ltd., India leadership team
Management profileNumber of profiles
Profiles3 records
Lincoln Pharmaceuticals Ltd., India subsidiaries and ownership
Company hierarchySubsidiaries4 records
Lincoln Pharmaceuticals Ltd., India funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Lincoln Pharmaceuticals Ltd., India M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Lincoln Pharmaceuticals Ltd., India
What does Lincoln Pharmaceuticals Ltd., India do?
Lincoln Pharmaceuticals Ltd. manufactures and markets pharmaceutical formulations including tablets, capsules, injectables, syrups, and ointments across 15 therapeutic areas such as anti-infective, respiratory, gynecology, cardio & CNS, anti-diabetic, and anti-malaria. The company has developed 600+ formulations and 1,700+ registered products, with proprietary novel drug delivery systems (NDDS), Transdermal Absorption Enhancer (TAE) technology, and PROGLET bilayer tablet technology. Products are sold domestically across 26 Indian states and exported to 60+ countries.
Is Lincoln Pharmaceuticals Ltd., India a public or private company?
Lincoln Pharmaceuticals Ltd., India is a public company. It is classified as public and is currently operating.
When was Lincoln Pharmaceuticals Ltd., India founded?
Lincoln Pharmaceuticals Ltd., India was founded in 1979. It employs 51 to 100 people.
Where is Lincoln Pharmaceuticals Ltd., India based?
Lincoln Pharmaceuticals Ltd., India is headquartered in Ahmedabad, India, in the Asia region.
How does Lincoln Pharmaceuticals Ltd., India make money?
One revenue line is on record: pharmaceutical Formulations Sales.
Who are Lincoln Pharmaceuticals Ltd., India's main competitors?
Direct peers on record are Ajanta Pharma, Natco Pharma, Alembic Pharmaceuticals, J B Chemicals & Pharmaceuticals, Unichem Laboratories, Strides Pharma, IPCA Laboratories and Emcure Pharmaceuticals. Broad incumbents are Glenmark Pharmaceuticals and Torrent Pharmaceuticals.
Does Lincoln Pharmaceuticals Ltd., India have an API?
No public API is recorded for Lincoln Pharmaceuticals Ltd., India.
What industry is Lincoln Pharmaceuticals Ltd., India in?
Lincoln Pharmaceuticals Ltd., India's product category is Pharmaceutical Formulations. Its primary akta.pro industry code is CRADAMAC, OTC Pain Relief & Fever (Analgesics, Anti-inflammatory, Topical Pain Relief), with a secondary code of HLAIAAAE, Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity). Its NAICS code is 325412 and its SIC code is 2834.